All In MedTech

Device Trial Radar · NCT05396599

A Clinical Study Comparing Postoperative Outcomes Between the TECNIS Intraocular Lens.

Last checked: Nov 20, 2026Latest source record: Jun 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

35

Actual

Start

Jun 30, 2022

Primary completion

Apr 7, 2023

Study completion Apr 7, 2023

Sponsor

Lead sponsor
Johnson & Johnson Surgical Vision, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 31, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, multi-center, masked, three-arm, randomized clinical study of the TECNIS Eyhance Toric II IOL (test #1) and TECNIS Synergy Toric II (test #2) compared to the TECNIS Toric 1-Piece IOL (control).

Conditions

  • Cataract

Interventions

  • Model DIUDevice

    Subjects will be randomized to a treatment group (masked) in ratio 1:1:1. Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with the lens to be implanted.

  • Model DFWDevice

    Subjects will be randomized to a treatment group (masked) in ratio 1:1:1. Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with the lens to be implanted.

  • Model ZCTDevice

    Subjects will be randomized to a treatment group (masked) in ratio 1:1:1. Surgeons will perform standardized, small-incision, cataract surgery and implant the study lenses using a JJSV-validated insertion system qualified for use with the lens to be implanted.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rotational Stability of IOLTime frame: 1 month

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Shultz Chang Vision

    Los Angeles, California

  • Coastal Vision

    Orange, California

  • Pacific Eye Associates, A Medical Corporation

    San Francisco, California

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.